Author : Mar, Author at PridCor Therapeutics

PridCor Therapeutics Advances SHIELD Study Through Dual.

TUSCALOOSA, Ala., Jan. 06, 2026 (GLOBE NEWSWIRE) — PridCor Therapeutics, a clinical-stage biopharmaceutical company developing antiviral therapies for infection-associated chronic illnesses including Long COVID, today.